Australian doctors are pushing for weight loss drugs like Ozempic, Wagovi and Mounjaro to be added to the PBS for obesity treatment. The health minister has received recommendations to list Wagovi on the PBS for people with a BMI of 35 and established cardiovascular disease, with price negotiations underway. Currently, more than 400,000 Australians pay private prices of up to $5,000 annually for these medications, with an estimated 6 million Australians suffering from obesity.

See omnystudio.com/listener for privacy information.

See omnystudio.com/listener for privacy information.